Categories
Onyx Biotec Limited — Board Meeting, 14-05-2026: Outcome of Board Meeting
14-05-2026 · 05:40 pm
Onyx Biotec Ltd.'s board approved standalone financial results for FY26. Revenue was ₹69.47 Cr, with a net loss of ₹0.02 Cr for the year. H2 FY26 saw a net profit of ₹0.69 Cr, turning around from H1's loss. IPO funds of ₹25.38 Cr were utilized as planned, with ₹2.14 Cr unutilized.
No comments yet. Be the first to comment!